RxSight (NasdaqGM:RXST) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsMark Wilterding - CFOOliver Murovec - Vice President of Investor RelationsRon Kurtz - President and CEOConference Call ParticipantsAdam Maeder - Senior Research AnalystAnthony Petrone - AnalystDanielle Antalffy - AnalystDavid Saxon - AnalystLarry Biegelsen - Senior Medical Technology AnalystSteven Lichtman - AnalystTom Stephan - AnalystNone - AnalystOperatorThank you for standing by. My name is Kate, and I will b ...

RxSight (NasdaqGM:RXST) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Speaker7Thank you for standing by. My name is Kate, and I will be your conference operator today. At this time, I would like to welcome everyone to the RxSight fourth quarter 2025 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star, followed by the ...